Evolution of the Average Target: Roche Holding AG

Evolution of the Target Price: Roche Holding AG

Changes in Analyst Recommendations: Roche Holding AG

5df8ec3752ed8376977a5010c7.mQxeLQJMfBn187_jYndye_Qnm2zt_fuJeFVX6cr1Am0.tEENWFofKWq7l_jWKQZFH7N18hS8q7fBHj8g0bqEaymseRFXcyYjbbel2A~ff31bec514714758bbd677ee91fe4a52
Sep. 30 Roche Holding AG : Deutsche Bank is Neutral ZD
Sep. 29 Roche Holding AG : Gets a Sell rating from Jefferies ZD
Sep. 29 Roche Holding AG : Deutsche Bank is Neutral ZD
Sep. 29 RBC Notes Roche's Long-term Pipeline Potential After 'Mixed' Pharma Day MT
Sep. 23 Berenberg: Roche's Pharma Day Expected to Highlight Breast Cancer Drugs, Among Others MT
Sep. 23 Roche Holding AG : Receives a Buy rating from RBC ZD
Sep. 23 Roche Holding AG : Berenberg remains Neutral ZD
Sep. 15 Roche Holding AG : Goldman Sachs reiterates its Neutral rating ZD
Sep. 09 RBC Capital Markets Starts Roche Coverage with Outperform Rating MT
Sep. 09 RBC Starts Roche Coverage at Outperform on Base Business Improvement, 'Underappreciated' Pipeline MT
Sep. 08 Roche Holding AG : RBC keeps its Buy rating ZD
Sep. 08 Roche Holding AG : Barclays maintains a Buy rating ZD
Aug. 28 Germany's DAX Index Extends Gains; BioNTech Tumbles After Scrapping Cancer Vaccine Trial MT
Aug. 20 Cancer vaccines finally garner the spotlight Alphavalue
Aug. 10 AlphaValue/Baader Europe Downgrades to Reduce, Lifts PT MT
Aug. 07 Morgan Stanley Upgrades Roche to Overweight, Boosts PT MT
Jul. 27 ROCHE HOLDINGS AG : Bernstein reaffirms its Buy rating ZD
Jul. 24 ROCHE HOLDINGS AG : Deutsche Bank sticks Neutral ZD
Jul. 24 Berenberg Lifts Roche Price Target Amid Upcoming Catalysts MT
Jul. 23 Roche Holding: Good Q2; late-stage pipeline execution key to sustained re-rating Alphavalue
Jul. 23 ROCHE HOLDINGS AG : Bernstein gives a Buy rating ZD
Jul. 23 Swiss stocks - Factors to watch on July 23 RE
Jul. 20 Wall Street's Patience Runs Thin Zonebourse
Jul. 20 Could AI chip boom make ASML Europe's first trillion-dollar firm? RE
Jul. 15 Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+16.27%
+9.08%
+6.1%
+7.94%
+8.57%
+8.12%
+34.02%
-3%
+9.61%
Average +10.75%
Weighted average by Cap. +11.42%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
345.70CHF
Average target price
375.34CHF
Spread / Average Target
+8.57%
High Price Target
434.50CHF
Spread / Highest target
+25.69%
Low Price Target
230.00CHF
Spread / Lowest Target
-33.47%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. ROP Stock
  4. 0QOK Stock
  5. Consensus Roche Holding AG